NEWPORT BEACH, CA-(NewMediaWire - Jun 5, 2017) - ADVANTIS
CORPORATION (OTC PINK: ADVT) is in negotiations with two high volume
cultivators in Nevada and Maryland to provide Amstercan solutions.
Delivery of a more efficient canning machine that N2pack has been
building for Advantis will be delivered within the next 6-8
weeks.
CEO of Advantis, Christopher Swartz, was excited to share the
news of Advantis' expansion to states they have not touched yet.
"Word about Amstercan is spreading quickly and demand is
persistently outstripping supply," Swartz stated. "This is a good
problem to have, but not one that we want to have for long; we're
chomping at the bit to get that new machine." The supplier of the
Amstercan canning machines and packaging solutions, N2 Pack, has
been building a new machine specifically to fulfill Advantis'
growing client demand. The machine is said to have more than triple
the production capacity of the current machine, and it will have
the option of sealing larger sized cans. "Las Vegas and Baltimore
are two huge marketplaces that could help fuel our national
expansion," Swartz added. "My further goal, as Amstercan expands
into other national marketplaces, is that we establish the
proprietary and non-proprietary product pipeline that we are doing
such a great job of creating here in California." Swartz noted that
they are considering options for when canning capacity is maximized
again, and said, "We need to keep up with demand as it continues to
skyrocket, and we are currently looking into several cost-effective
solutions."
Swartz pointed out that in addition to the reduction of manpower
necessary to operate the new canning machine, Advantis is taking
other cost cutting measures. "We are bringing the can labeling
process in-house," Swartz said. "We have been working with an
outstanding labeling company, but we are not their only client, and
that means we can't always get things done in the same day. Not
only are we cutting costs by bringing this process in-house, but we
will be able to service our clients faster." Swartz says with the
reduction of manufacturing costs, margins from sales of Amstercans
will increase by over 10%.
The industry is trending toward the premium packaging, branding,
and preserving of cannabis. "As it continues to evolve, we grow,"
Swartz said. "Product identity, increased shelf life, easy storage
and inventory control; the industry's natural course is for
products to strive toward the goal that every other product in the
marketplace strives for: Brand name recognition." Swartz says that
brand recognition is of paramount importance to every Amstercan
client they deal with. "My further goal, with Amstercan expanding
into other marketplaces throughout the nation, is that we establish
the proprietary and non-proprietary product pipeline that we are
doing such a great job of creating here in California."
Swartz planned another quarterly interview to update
shareholders on past performance and future prospects within two
weeks of the earnings release, however scheduling conflicts with
the interviewer prevented it from taking place. Advantis is
expecting confirmation of the date and time of the rescheduled
interview shortly.
Links to Advantis websites can be found at advantiscorp.com, rosin6.com, elixicure.com, and amstercan.com
Social Media Instagram Facebook
About Advantis Corporation
Advantis Corporation (ADVT) focuses on the development of
innovative products that supply the medical, research, and
pharmaceutical industries. The company additionally establishes
domestic and international partnerships with businesses that
develop and sell proprietary pain management, and consumer products
and services.
Forward Looking Statements: This news release contains
forward-looking statements made by ADVANTIS CORPORATION. All such
statements included in this press release, other than statements of
historical fact, are forward-looking statements. Although
management believes that the expectations reflected in such
forward-looking statements are reasonable, it can give no assurance
that such expectations will prove to have been correct. Actual
results may differ materially from those indicated by these
statements. The following risk factors, among others, could cause
actual results to differ materially from those described in any
forward- looking statements. These risks and uncertainties include,
but are not limited to, economic conditions, changes in the law or
regulations, demand for products of the Company, the effects of
competition and other factors that could cause actual results to
differ materially from those projected or represented in the
forward looking statements. Forward- looking statements are
typically identified by the words: believe, expect, anticipate,
intend, estimate, and similar expressions or which by their nature
refer to future events. The Company is not entitled to rely on the
safe harbor provisions of Section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934 because it
is not registered under either Act.